The Coriell Institute for Medical Research is partnering with Ohio State University Medical Center physicians to incorporate genetic risk information into their patients' electronic medical records, according to a news release.
The incorporation of genomic data will be done through the Coriell Personalized Medicine Collaborative research study, the goal of which is to understand the utility of genome information in patient care and develop best practices for personalized medicine.
The collaboration will involve 30-35 OSU Medical Center cardiologists and primary care physicians and 1,800 of their patients, all of whom are diagnosed with either congestive heart failure or hypertension. Patients' genomic information will be entered into the EMRs, and observations will be made as to how their physicians use the personalized genetic risk information to make clinical care decisions. The study will be used to indicate whether genome-informed medicine has utility in practice and how likely physicians are to use the information when it is made available to them.
The impact of genetic counseling on patient behaviors will also be studied.
Read the news release about the Coriell Personalized Medicine Collaborative research study (pdf).
Read other coverage about electronic medical records:
- Number of Registrants for Incentive Payments Will on the Rise
- ONC Awards Contracts to Test Effectiveness of EMRs
- Survey: 24% of Physicians Concerned About Negative Effects of EMR on Healthcare
The incorporation of genomic data will be done through the Coriell Personalized Medicine Collaborative research study, the goal of which is to understand the utility of genome information in patient care and develop best practices for personalized medicine.
The collaboration will involve 30-35 OSU Medical Center cardiologists and primary care physicians and 1,800 of their patients, all of whom are diagnosed with either congestive heart failure or hypertension. Patients' genomic information will be entered into the EMRs, and observations will be made as to how their physicians use the personalized genetic risk information to make clinical care decisions. The study will be used to indicate whether genome-informed medicine has utility in practice and how likely physicians are to use the information when it is made available to them.
The impact of genetic counseling on patient behaviors will also be studied.
Read the news release about the Coriell Personalized Medicine Collaborative research study (pdf).
Read other coverage about electronic medical records:
- Number of Registrants for Incentive Payments Will on the Rise
- ONC Awards Contracts to Test Effectiveness of EMRs
- Survey: 24% of Physicians Concerned About Negative Effects of EMR on Healthcare